Cure Today

Latest Advocacy Group Content

Treatments for Men Whose Prostate Cancer Has Spread and Become Resistant to Hormonal Therapy are Growing

FDA Updates Breast Implant Labeling Recommendations to Help Inform Patients About Dangerous Potential Side Effects

Friday Frontline: Smartphone app encourages smoking cessation, House passes Veteran’s Prostate Cancer Treatment and Research Act, and More

Program Leads Patients With Cancer on ‘The Right Track’

Latest Content

What the FDA’s New Breast Implant Recommendations Mean for Patients

September 30th 2020, 6:00pm

By Jessica Skarzynski

Video

In an interview with CURE®, the president of the National Center for Health Research elaborates on the effort to protect patients from potentially serious side effects associated with getting breast implants, including breast implant-associated anaplastic large cell lymphoma.

How to Find Solutions for the Side Effects of Cancer Treatment

September 30th 2020, 4:00pm

By Marissa Holzer

Article

Cancer, unfortunately, forces you to adapt or be miserable. There’s a solution to the side effects of treatment out there. You just have to find it.

There is Help for Patients Dealing with Sexual Side Effects After Prostate, Bladder Cancer Treatment

September 30th 2020, 3:00pm

By Marilyn Fenichel

Article

After treatment for bladder or prostate cancer, many survivors confront permanent sexual side effects. The good news is that treatments and psychological support are available.

Phase 2 Study of VERU-111 in Prostate Cancer Subgroup Completes Patient Enrollment

September 30th 2020, 1:00pm

By Kristie L. Kahl

Article

VERU Inc. announced it has completed enrollment of 40 men with metastatic prostate cancer who have become resistant to at least one androgen receptor targeting agent for its phase 2 study of VERU-111.

Long-Term Evidence Confirms Benefit of Approved Lynparza Maintenance Strategy in Advanced Ovarian Cancer

September 29th 2020, 7:00pm

By Beth Fand Incollingo

Article

Five-year follow-up data from the phase 3 SOLO-1 trial demonstrates a nearly five-year delay in disease progression with Lynparza compared with a delay of just over a year with placebo in women with newly diagnosed, advanced ovarian cancer harboring a BRCA gene mutation.

How I Learned to Embrace the 'New Me' After Cancer

September 29th 2020, 4:00pm

By Martha Carlson

Article

I get asked, a lot, about how to return to normal while living with cancer. I don’t want to be returning to the past since I’d rather be looking toward the future.

While Penile Cancer is Rare, Men Should Be Aware

September 29th 2020, 3:00pm

By Beth Fand Incollingo

Article

A woman shares her late husband’s journey with advanced penile cancer to help others receive a diagnosis early, when the disease is still highly treatable and even curable.

How Has an Oncology Nurse Helped You on Your Cancer Journey?

September 29th 2020, 1:00pm

By Ryan McDonald

Article

On social media, CURE® recently asked its readers to share how an oncology nurse has helped them on their cancer journey.

After A Positive Experience While Receiving Treatment for Testicular Cancer, Student Pilot Volunteers to Transport Pets in Need

September 28th 2020, 9:00pm

By Beth Fand Incollingo

Article

After enjoying visits from therapy dogs during treatment for testicular cancer, a student pilot decides to volunteer to transport pets needing rescue, shelter or adoption.

Dose-Dense Chemo Regimen No Better Than Standard of Care for Epithelial Ovarian Cancer

September 28th 2020, 6:00pm

By Brielle Benyon

Article

A weekly high dose of chemotherapy did not improve survival for patients with epithelial ovarian cancer, though the treatment regimen was effective and well-tolerated.